VanEck Pharmaceutical ETF
Health/Biotechnology
PPH
666 THIRD AVENUE, 9TH FLOOR,
NEW YORK , NY, 10017
NEW YORK , NY, 10017
Price
-
$ 83.01
0 %
-0.9
Dec 20, 2024
- Last Close
- Net Assets
-
$450.6M
Feb 22, 2024
- 52-Week High/Low
- $89.92 - $75.44
- Expense Ratio
- -
Link
Directors
Dec 13, 2023- Laurie A. Hesslein
- R. Alastair Short
- Richard D. Stamberger
- Peter J. Sidebottom
- David H. Chow
- Jan F. Van Eck
Chief Compliance Officer
- Francesco Michael Gozzillo
Company Name |
Holding |
| More | 4.42 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | 3.3% | -0.1% | 4.6% | 3.8% | -15.2% | 10.1% |
| Q2 | -1.7% | 1.5% | -3.7% | 7.3% | 14.5% | -3.2% |
| Q3 | - | 1.4% | -12.5% | 0.1% | -1.8% | -3% |
| Q4 | - | 2.8% | 15.6% | 5.7% | 6.9% | 12.4% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -3% | 4.1% | 2.4% | -2.4% | 1.6% | - | - | - | - | - | - | - |
| 2023 | 0.8% | -3.4% | 2.6% | 1.6% | -4.1% | 4.1% | 2.1% | 1.8% | -2.5% | -5.7% | 4.3% | 3.6% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.4% | 4.7% | 1.9% | 16.8% | 1.9% | 17% | -5.9% | 15.2% | -17.8% | 3.5% | 23.2% |